RPCI-UPCI Ovarian Cancer SPORE brings together basic and applied investigators to conduct innovative and diverse translational investigations aimed at risk stratification, treatment of primary and recurrent ovarian cancer, and prevention of relapse in patients in remission. Read more.
Information for Patients
Ovarian cancer is the fifth leading cause of cancer death in women. This SPORE project aims to reduce the prevalence of ovarian cancer and increase survival rates for patients. Read more.
Each RPCI-UPCI Ovarian Cancer SPORE clinical trial addresses a distinct population of ovarian cancer patients, based on the natural history of disease. Read more.